| Company Name: |
LGM Pharma |
| Tel: |
1-(800)-881-8210 |
| Email: |
inquiries@lgmpharma.com |
| Company Name: |
Energy Chemical |
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | ILMOFOSINE Basic information |
| Product Name: | ILMOFOSINE | | Synonyms: | 3-(hexadecylthio)-2-(MethoxyMethyl)propyl 2-(triMethylaMMonio)ethyl phosphate;3,5-Dioxa-9-thia-4-phosphapentacosan-1-aMiniuM, 4-hydroxy-7-(MethoxyMethyl)-N,N,N-triMethyl-, inner salt, 4-oxide;BM 41.440, 1-Hexadecylmercapto-2-methoxymethyl-3-propyl phosphoric acid monocholine ester;4-Oxylato-7-(methoxymethyl)-N,N,N-trimethyl-3,5-dioxa-4-oxo-9-thia-4-phospha(V)pentacosan-1-aminium;7-(Methoxymethyl)-N,N,N-trimethyl-4-oxylato-4-oxo-3,5-dioxa-9-thia-4-phospha(V)pentacosan-1-aminium;4-Oxylato-7-(methoxymethyl)-N,N,N-trimethyl-3,5-dioxa-9-thia-4-phospha(V)pentacosan-1-aminium4-oxide;1-Hexadecylthio-2-methoxymethyl-rac-glycero-3-phosphocholine;3,5-Dioxa-9-thia-4-phosphapentacosan-1-aminium, 4-hydroxy-7-(methoxymethyl)-N,N,N-trimethyl-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))- | | CAS: | 83519-04-4 | | MF: | C26H56NO5PS | | MW: | 525.77 | | EINECS: | | | Product Categories: | | | Mol File: | 83519-04-4.mol |  |
| | ILMOFOSINE Chemical Properties |
| storage temp. | −20°C | | solubility | H2O: soluble10mg/mL | | form | semisolid (waxy) |
| Hazard Codes | Xn | | Risk Statements | 22 | | RIDADR | UN 2811 6.1/PG 3 | | WGK Germany | 3 | | RTECS | JH4758000 |
| | ILMOFOSINE Usage And Synthesis |
| Uses | Ilmofosine is a PKC inhibitor with efficacy against a variety of cancer cell lines. |
| | ILMOFOSINE Preparation Products And Raw materials |
|